ADMA BIOLOGICS, INC. Earnings Per Share (Diluted)
ADMA BIOLOGICS, INC. (ADMA) reported Earnings Per Share (Diluted) of $0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- ADMA BIOLOGICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.16, a 14.29% increase year-over-year.
- ADMA BIOLOGICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.19, a 72.73% increase year-over-year.
- ADMA BIOLOGICS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $0.20, a 54.99% decline year-over-year.
- ADMA BIOLOGICS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.15, a 0.00% change year-over-year.
- ADMA BIOLOGICS, INC. earnings per share, diluted for fiscal 2025 was $0.60, a 25.93% decline from fiscal 2024.
- ADMA BIOLOGICS, INC. earnings per share, diluted for fiscal 2024 was $0.81.
- ADMA BIOLOGICS, INC. earnings per share, diluted for fiscal 2023 was -$0.13.
- ADMA BIOLOGICS, INC. earnings per share, diluted for fiscal 2022 was -$0.33.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.16 10-Q · filed 2026-08-05 | $0.35 10-Q · filed 2026-08-05 | $0.56 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.71 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | $0.19 10-Q · filed 2026-05-06 | $0.39 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.54 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.68 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $0.20 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.35 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.49 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.60 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.15 10-Q · filed 2025-11-05 | $0.29 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.40 10-Q · filed 2025-11-05 | $0.85 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | $0.14 10-Q · filed 2026-08-05 | $0.25 10-Q · filed 2026-08-05 | $0.70 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.85 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | $0.11 10-Q · filed 2026-05-06 | $0.56 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.71 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.84 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | $0.45 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.60 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.73 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.81 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.15 10-Q · filed 2025-11-05 | $0.28 derived: net income ÷ weighted average shares · filed 2025-11-05 | $0.35 10-Q · filed 2025-11-05 | $0.29 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2024-06-30 | $0.13 10-Q · filed 2025-08-06 | $0.21 10-Q · filed 2025-08-06 | $0.14 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.15 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2024-03-31 | $0.08 10-Q · filed 2025-05-07 | $0.00 derived: net income ÷ weighted average shares · filed 2026-04-15 | $0.01 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2023-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.13 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.01 10-Q · filed 2024-11-07 | -$0.02 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.05 10-Q · filed 2024-11-07 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2023-06-30 | -$0.03 10-Q · filed 2024-08-08 | -$0.06 10-Q · filed 2024-08-08 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2023-03-31 | -$0.03 10-Q · filed 2024-05-09 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2022-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.33 10-K · filed 2025-03-18 |
| 2022-09-30 | -$0.08 10-Q · filed 2023-11-08 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.27 10-Q · filed 2023-11-08 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2022-06-30 | -$0.07 10-Q · filed 2023-08-09 | -$0.20 10-Q · filed 2023-08-09 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2022-03-31 | -$0.13 10-Q · filed 2023-05-10 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2021-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.51 10-K · filed 2024-02-28 |
| 2021-09-30 | -$0.13 10-Q · filed 2022-11-09 | -$0.28 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.44 10-Q · filed 2022-11-09 | -$0.63 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-10 | -$0.31 10-Q · filed 2022-08-10 | -$0.50 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-03-31 | -$0.16 10-Q · filed 2022-05-11 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.78 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2020-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$0.63 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$0.88 10-K · filed 2022-03-24 |
| 2020-09-30 | -$0.19 10-Q · filed 2021-11-10 | -$0.43 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.68 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$0.23 10-Q · filed 2021-08-11 | -$0.49 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |